Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Tevogen Inc

TVGN ✓ COMPLIANTFree checks used up today ☆ Track — members

NASDAQ · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$5.90

▼ -2.48%

Market Cap $38.42M · Vol 1.56K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$38.42M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

32.19

Momentum

Beta

0.22

vs Market

52W High

$32.50

81.85% below

52W Low

$3.79

55.67% above

Volume

1.56K

Avg 1.69K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

28.22%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Tevogen Inc (TVGN) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TVGN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-9.65%

-10.88%

-12.20%

-11.14%

YTD

-64.36%

-80.35%

-98.91%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-26,275,430.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-669.89% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	6.51M

Technical Indicators

50-Day SMA	$6.97
200-Day SMA	$8.19
RSI (14)	32.19
Beta	0.22
52-Week High	$32.50
52-Week Low	$3.79

Volume Today	1.56K
Avg Daily Volume (30D)	1.69K
Relative Volume	0.92x
Volatility (10D)	44.66
Volatility (30D)	62.53
Free Float	28.22%

Analyst Consensus

N/A

Current Price $5.90

Mean Target N/A

52W Low$3.79 52W High$32.50

Current

Target

$3.79 $32.50

Current Analyst target

· 0 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG0133954Z7

ISINUS88165K2006

CountryUSA

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG +0.53% ONC BeOne Medicines AG -0.33% 068270.KS Celltrion, Inc. +1.22% MEDP Medpace Holdings, Inc. -3.77% CRL Charles River Laboratories International, Inc. -4.44%

Company Profile

Tevogen Inc., formerly Tevogen Bio Holdings Inc., is a socially integrated healthcare enterprise. The Company leverages artificial intelligence and precision T cell therapy platforms, and engagements with global technology companies to support the development of advanced, life-saving therapies across multiple therapeutic areas and scalable solutions for the broader healthcare system. Tevogen Bio, its lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of its single-HLA-restricted, genetically unmodified allogeneic T cells. Tevogen Bio's pipeline spans virology, oncology, and neurology. Tevogen.AI is designed to transform drug development by accelerating target detection, helping reduce failure rates, and supporting optimized clinical trial design through proprietary predictive technologies. It is exploring strategic initiatives that may include domestic generics, biosimilars, medical devices, and insurance solutions for healthcare providers.